BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37211286)

  • 1. Comparison of outcomes of EUS-guided ablation and surveillance only for pancreatic cystic lesions: a propensity score-matching study (with videos).
    Song YJ; Huh G; Kim EH; Lee JB; Park DH
    Gastrointest Endosc; 2023 Oct; 98(4):585-596.e3. PubMed ID: 37211286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of endoscopic ultrasound-guided ethanol ablation for pancreatic cystic lesions: A single-center experience of 214 patients.
    Choi JH; Lee SH; Choi YH; You MS; Shin BS; Paik WH; Ryu JK; Kim YT
    Hepatobiliary Pancreat Dis Int; 2019 Dec; 18(6):562-568. PubMed ID: 31551143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of EUS-guided ablation and surgical resection for nonfunctioning small pancreatic neuroendocrine tumors: a propensity score-matching study.
    So H; Ko SW; Shin SH; Kim EH; Son J; Ha S; Song KB; Kim HJ; Kim MH; Park DH
    Gastrointest Endosc; 2023 Apr; 97(4):741-751.e1. PubMed ID: 36400239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of branch-duct intraductal papillary mucinous neoplasms: a large single-center study to assess predictors of malignancy and long-term outcomes.
    Ridtitid W; DeWitt JM; Schmidt CM; Roch A; Stuart JS; Sherman S; Al-Haddad MA
    Gastrointest Endosc; 2016 Sep; 84(3):436-45. PubMed ID: 26905937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with misdiagnosis of preoperative endoscopic ultrasound in patients with pancreatic cystic neoplasms undergoing surgical resection.
    Ohno E; Ishikawa T; Mizutani Y; Iida T; Uetsuki K; Yashika J; Yamada K; Gibo N; Aoki T; Kawashima H
    J Med Ultrason (2001); 2022 Jul; 49(3):433-441. PubMed ID: 35411413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management and outcomes of intraductal papillary mucinous neoplasms.
    Hipp J; Mohamed S; Pott J; Sick O; Makowiec F; Hopt UT; Fichtner-Feigl S; Wittel UA
    BJS Open; 2019 Aug; 3(4):490-499. PubMed ID: 31388641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes of endoscopic ultrasound-guided ethanol ablation for pancreatic cystic lesions compared with the natural course: a propensity score matching analysis.
    Choi JH; Lee SH; Choi YH; Kang J; Paik WH; Ahn DW; Ryu JK; Kim YT
    Therap Adv Gastroenterol; 2018; 11():1756284818759929. PubMed ID: 29535793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid Growth Rates of Suspected Pancreatic Cyst Branch Duct Intraductal Papillary Mucinous Neoplasms Predict Malignancy.
    Kwong WT; Lawson RD; Hunt G; Fehmi SM; Proudfoot JA; Xu R; Giap A; Tang RS; Gonzalez I; Krinsky ML; Savides TJ
    Dig Dis Sci; 2015 Sep; 60(9):2800-6. PubMed ID: 25924899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross Validation of the Monoclonal Antibody Das-1 in Identification of High-Risk Mucinous Pancreatic Cystic Lesions.
    Das KK; Geng X; Brown JW; Morales-Oyarvide V; Huynh T; Pergolini I; Pitman MB; Ferrone C; Al Efishat M; Haviland D; Thompson E; Wolfgang C; Lennon AM; Allen P; Lillemoe KD; Fields RC; Hawkins WG; Liu J; Castillo CF; Das KM; Mino-Kenudson M
    Gastroenterology; 2019 Sep; 157(3):720-730.e2. PubMed ID: 31175863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A large multicenter study of recurrence after surgical resection of branch-duct intraductal papillary mucinous neoplasm of the pancreas.
    Yan L; Siddiqui AA; Laique SN; Saumoy M; Kahaleh M; Yoo J; Kalra A; Mathew A; Sterling J; Rao R; Lieberman M; Cosgrove N; Sharaiha RZ
    Minerva Gastroenterol Dietol; 2017 Mar; 63(1):50-54. PubMed ID: 27824244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EUS is accurate in characterizing pancreatic cystic lesions; a prospective comparison with cross-sectional imaging in resected cases.
    Wesali S; Demir MA; Verbeke CS; Andersson M; Bratlie SO; Sadik R
    Surg Endosc; 2021 Dec; 35(12):6650-6659. PubMed ID: 33259018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression of Pancreatic Branch Duct Intraductal Papillary Mucinous Neoplasm Associates With Cyst Size.
    Han Y; Lee H; Kang JS; Kim JR; Kim HS; Lee JM; Lee KB; Kwon W; Kim SW; Jang JY
    Gastroenterology; 2018 Feb; 154(3):576-584. PubMed ID: 29074452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can contrast-enhanced harmonic endoscopic ultrasonography accurately diagnose main pancreatic duct involvement in intraductal papillary mucinous neoplasms?
    Ohno E; Kawashima H; Ishikawa T; Iida T; Suzuki H; Uetsuki K; Yashika J; Yamada K; Yoshikawa M; Gibo N; Aoki T; Kataoka K; Mori H; Hirooka Y; Fujishiro M
    Pancreatology; 2020 Jul; 20(5):887-894. PubMed ID: 32651080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher Growth Rate of Branch Duct Intraductal Papillary Mucinous Neoplasms Associates With Worrisome Features.
    Kolb JM; Argiriadi P; Lee K; Liu X; Bagiella E; Gupta S; Lucas AL; Kim MK; Kumta NA; Nagula S; Sarpel U; DiMaio CJ
    Clin Gastroenterol Hepatol; 2018 Sep; 16(9):1481-1487. PubMed ID: 29535058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Outcomes of Endoscopic Ultrasonography-Guided Pancreatic Cyst Ablation.
    Park JK; Song BJ; Ryu JK; Paik WH; Park JM; Kim J; Lee SH; Kim YT
    Pancreas; 2016 Jul; 45(6):889-94. PubMed ID: 26765962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracystic injection of large surface area microparticle paclitaxel for chemoablation of intraductal papillary mucinous neoplasms: Insights from an expanded access protocol.
    Krishna SG; Ardeshna DR; Shah ZK; Hart PA; Culp S; Jones D; Chen W; Papachristou GI; Han S; Lee PJ; Shah H; Pawlik TM; Dillhoff M; Manilchuk A; Cloyd J JM; Ejaz A; Fry M; Noonan AM
    Pancreatology; 2024 Mar; 24(2):289-297. PubMed ID: 38238194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk Factors for Pancreatic Cancer and the Necessity of Long-Term Surveillance in Patients With Pancreatic Cystic Lesions.
    Yoshioka T; Shigekawa M; Ikezawa K; Tamura T; Sato K; Urabe M; Sueyoshi H; Yamai T; Suda T; Sakamori R; Tatsumi T; Takehara T
    Pancreas; 2020 Apr; 49(4):552-560. PubMed ID: 32282769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term Risk of Pancreatic Malignancy in Patients With Branch Duct Intraductal Papillary Mucinous Neoplasm in a Referral Center.
    Pergolini I; Sahora K; Ferrone CR; Morales-Oyarvide V; Wolpin BM; Mucci LA; Brugge WR; Mino-Kenudson M; Patino M; Sahani DV; Warshaw AL; Lillemoe KD; Fernández-Del Castillo C
    Gastroenterology; 2017 Nov; 153(5):1284-1294.e1. PubMed ID: 28739282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of Undifferentiated Solitary Mucinous Cystic Lesion of the Pancreas: A Clinical Dilemma.
    Roch AM; Bigelow K; Schmidt CM; Carr RA; Jester AL; Ceppa EP; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
    J Am Coll Surg; 2017 Apr; 224(4):717-723. PubMed ID: 28126546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-Risk Characteristics Associated with Advanced Pancreatic Cystic Lesions: Results from a Retrospective Surgical Cohort.
    Sun L; Wang W; Zhu H; Jiang F; Peng L; Jin G; Jin Z
    Dig Dis Sci; 2021 Jun; 66(6):2075-2083. PubMed ID: 32705437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.